Wockhardt Ltd reported its Q1 FY26 results showing a revenue of INR 738 Cr, a slight decline from INR 747 Cr last year, and an EBITDA of INR 101 Cr, up from INR 100 Cr; the report also covers advances in their Novel Antibiotics development.